Myo-Inositol PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Myo-Inositol PCD pharma franchise company offering 10 WHO-GMP certified Myo-Inositol formulations manufactured in DCGI-approved facilities. Our range is supplied to franchise partners across India with district-wise monopoly rights.
What is Myo-Inositol?
Myo-Inositol is a naturally occurring sugar alcohol (carbocyclic polyol) involved in cellular signalling and insulin sensitivity. It is widely used as a nutraceutical to support metabolic and reproductive health, particularly in women managing polycystic ovary syndrome (PCOS). Learn more on PubChem.
Available Myo-Inositol Formulations
Our Myo-Inositol portfolio spans 10 formulations across the following dosage forms: Sachet, Softgel and Tablets. This lets partners serve multiple patient segments from a single supplier.
Therapeutic Applications
Myo-Inositol is used to support metabolic and reproductive health, most notably in the management of PCOS, insulin resistance and fertility. It is commonly recommended by gynaecologists, endocrinologists and fertility specialists.
Why Myo-Inositol is a High-Potential Molecule for Distributors
With rising awareness of PCOS and metabolic wellness, Myo-Inositol enjoys strong, growing demand in the women-health and nutraceutical segments. Its supplement status and repeat-use profile make it a high-turnover addition to any franchise portfolio.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP and DCGI-approved manufacturing, timely supply and complete promotional inputs. With 1000+ franchise partners, we back every associate marketing our Myo-Inositol range with reliable support.
References
- PubChem - myo-Inositol
- PubMed - Myo-Inositol research
Our formulations of Myo-Inositol find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: